Autonomix Medical Granted U.S. Patent Titled 'Systems And Methods For Treating Cancer And/Or Augmenting Organ Function'
The patent expands the Company’s intellectual property protection for technologies designed to sense, map and selectively target nerves associated with tumors, cancer-related pain, organ function and other autonomic
Autonomix Medical got official permission from the U.S. government to protect a new invention that helps doctors find and treat cancer and organ problems using special nerve-targeting technology. When a company gets a patent, it means their idea is unique and protected, which can make the company more valuable—watch to see if they actually use this invention to help patients.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.